research reports

Marketing

Pharma ESG efforts skew social, PwC study finds

A whopping 77% of pharma ESG efforts over the past 16 months were social, while just 12% were environmental and 11% governance, according to PwC.
Beth Snyder Bulik Aug 19, 2021 9:30am

J&J's Ponvory late to MS market, but docs still see potential

Aug 10, 2021 11:00am

Pharma's physician payments still deliver big ROI, study finds

Dec 3, 2020 10:05am

Novartis finds employer support matters when treating migraines

Jun 15, 2020 11:39am

Pharma and ad agencies zero in on payer marketing

Aug 29, 2018 10:15am

Migraine study backs treatment expansion

Jul 25, 2018 10:11am